ORCID as entered in ROS

Select Publications
1997, 'HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides', Journal of Experimental Medicine, 185, pp. 367 - 371, http://dx.doi.org/10.1084/jem.185.2.367
,1997, 'A distinctive peptide binding motif for HLA-DRB1(*)0407, an HLA-DR4 subtype not associated with rheumatoid arthritis', Immunogenetics, 45, pp. 229 - 232, http://dx.doi.org/10.1007/s002510050196
,1996, 'Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library', Immunology, 88, pp. 482 - 486, http://dx.doi.org/10.1046/j.1365-2567.1996.d01-693.x
,1996, 'Evolution of allorecognition?', Immunology Today, 17, pp. 589 - 590, http://dx.doi.org/10.1016/S0167-5699(97)84208-9
,1996, 'Reverse immunogenetics: From HLA-disease associations to vaccine candidates', Molecular Medicine Today, 2, pp. 38 - 45, http://dx.doi.org/10.1016/1357-4310(96)88757-0
,1995, 'A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide', International Immunology, 7, pp. 1599 - 1605, http://dx.doi.org/10.1093/intimm/7.10.1599
,1995, 'The promiscuous B27 hypothesis', Lancet, 346, pp. 500 - 501, http://dx.doi.org/10.1016/S0140-6736(95)91348-3
,1995, 'Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain', Proceedings of the National Academy of Sciences of the United States of America, 92, pp. 6567 - 6571
,1995, 'Antagonists or altruists: do viral mutants modulate T-cell responses?', Immunology Today, 16, pp. 432 - 436, http://dx.doi.org/10.1016/0167-5699(95)80020-4
,1995, 'An empirical method for the prediction of T-cell epitopes', Immunogenetics, 42, pp. 392 - 397, http://www.ncbi.nlm.nih.gov/pubmed/7590973
,1994, 'Human leukocyte antigens and natural selection by malaria', Philosophical Transactions of the Royal Society B Biological Sciences, 346, pp. 379 - 383, http://dx.doi.org/10.1098/rstb.1994.0155
,1994, 'Identification of a Mycobacterium leprae‐specific T cell epitope on the 70 kDa heat shock protein', Immunology and Cell Biology, 72, pp. 215 - 221, http://dx.doi.org/10.1111/j.1440-1711.1994.tb03780.x
,1993, 'Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein', Infection and Immunity, 61, pp. 135 - 141
,1992, 'The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses', Infection and Immunity, 60, pp. 1170 - 1177
,2023, 'Impact of CD4 binding-site bNAb therapy on virus-specific T cell immunity in barcoded TF-SHIV-infected rhesus macaques during antiretroviral treatment interruption', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, pp. 332 - 333
,2022, 'CD8(+) T cell depletion does not affect viral reservoir size, but influences the rebound after ART interruption in SIV-infected rhesus macaques', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, pp. 323 - 324, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design', in Journal of Infectious Diseases, Oxford University Press (OUP), United States, pp. 236 - 245, United States, http://dx.doi.org/10.1093/infdis/jiac032
,2018, 'CD8+T Cells Do Not Control SIV Replication During ART or Viral Relapse After ART Withdrawal', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SPAIN, Madrid, pp. 33 - 33, presented at HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science, SPAIN, Madrid, 21 October 2018 - 25 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000448371600042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'The absence of Aire does not alter the CD8 T cell repertoire to infection', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209763601194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'HIV EPIDEMIOLOGY AND THE IMPACT OF NONSTERILIZING VACCINES', in BIOMAT 2006, WORLD SCIENTIFIC, pp. 69 - 88, presented at International Symposium on Mathematical and Computational Biology, http://dx.doi.org/10.1142/9789812708779_0005
,2022, 'OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab', Vol. 8, pp. 100153 - 100153, http://dx.doi.org/10.1016/j.jve.2022.100153
,2022, 'PP 2.3 – 00034 CD8+ T-Cell Sieving During SIV Reactivation from Latency', Vol. 8, pp. 100159 - 100159, http://dx.doi.org/10.1016/j.jve.2022.100159
,2024, 'TCR repertoire diversity allows for expansion of HIV-specific CD8 T-cells following anti-PD1 in people with HIV and cancer on ART', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 27, pp. 4 - 4
,2022, 'Early antiretroviral therapy in SIV-infected rhesus macaques reveals a highly dynamic accumulation of the rebound competent viral reservoir', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 51, pp. 303 - 303, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Enforced lymphoid tissue retention of CD8(+) T cells in SIV-infected Rhesus Macaques does not induce control of SIV plasma viremia', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 51, pp. 318 - 318, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Impact of CD4 binding-site bNAb therapy on viral rebound in barcoded TF-SHIV-D-infected rhesus macaques at ATI', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 51, pp. 301 - 302, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Exposure to host inflammation in vivo induces rapid transcriptomic change and impaired maturation in malaria parasites', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713665801305&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Microbial exposure in early life alters the ontogeny and function of CD8+T cells', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713665801448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'CD8+T cells provide limited control of SIV reactivation after combination antiretroviral therapy (cART) cessation', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 49, pp. 238 - 239, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000571653100042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Fingolimod treatment at ART initiation delays SIV rebound after ART interruption', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 22, pp. 43 - 43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476890500090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Assessing individual viral reactivations of the latent reservoir using a novel barcoded virus', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 1 - 1, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Frequent and "burst-like'' reactivation from latency in SIVmac239M infected macaques', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine., http://dx.doi.org10.1101/2022.02.20.481163, https://www.ncbi.nlm.nih.gov/pubmed/35233575
,2021, SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection., http://dx.doi.org10.1101/2021.12.08.21267417, https://www.ncbi.nlm.nih.gov/pubmed/34909788
,2019, Matryoshka RNA virus 1: a novel RNA virus associated with Plasmodium parasites in human malaria, http://dx.doi.org10.1101/624403
,2025, Dissecting the steps in early Simian Immunodeficiency Virus dissemination following mucosal and intravenous infection of rhesus macaques, http://dx.doi.org/10.1101/2025.03.24.644849
,2025, Therapeutic CD8+T cell tissue retention and immunomodulation during ART interruption fails to prevent SIV rebound, http://dx.doi.org/10.1101/2025.03.17.643755
,2025, Single-cell multiomics reveals the distinct properties of neonatal and adult recent thymic emigrants, http://dx.doi.org/10.1101/2025.02.26.640106
,2025, Recent thymic emigrants are preferentially recruited into the memory pool during persistent infection., http://dx.doi.org/10.1101/2025.02.06.636722
,2024, Affinity of the Transmitted Founder Virus Drives Early Emergence of Hepatitis C Virus Specific Neutralising Antibodies, http://dx.doi.org/10.2139/ssrn.4935049
,2024, Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans, http://dx.doi.org/10.1101/2024.07.25.24311039
,2024, Optimal deployment of limited vaccine supplies to combat mpox, http://dx.doi.org/10.1101/2024.11.03.24316551
,2024, Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19, http://dx.doi.org/10.1101/2024.05.14.24307386
,2024, Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants, http://dx.doi.org/10.1101/2024.09.01.610733
,2024, Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates, http://dx.doi.org/10.1101/2024.02.08.24302032
,2023, Durable reprogramming of neutralising antibody responses following breakthrough Omicron infection, http://dx.doi.org/10.1101/2023.02.19.23286159
,2023, Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough, http://dx.doi.org/10.1101/2023.03.28.23287848
,2023, Mucosal and Systemic Immune Correlates of Viral Control following SARS-CoV-2 Infection Challenge in Seronegative Adults, http://dx.doi.org/10.1101/2023.07.21.23292994
,2023, Predicting vaccine effectiveness in Mpox, http://dx.doi.org/10.1101/2023.11.23.23298850
,2023, Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2023.06.18.23291566
,